Home
/
RELMADA THERAPEUTICS, INC.
/
Financials
/
Quarterly
RELMADA THERAPEUTICS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that RELMADA THERAPEUTICS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2014
Feb 28, 2014
$682
Apr 15, 2014
Q1
2014
Nov 30, 2013
$1.9K
Jan 13, 2014
Q3
2013
May 31, 2013
$634
Jul 12, 2013
Q2
2013
Feb 28, 2013
$2.3K
May 3, 2013
Q1
2014
Nov 30, 2012
$2.1K
Jan 13, 2014
Q3
2013
May 31, 2012
$400
Jul 12, 2013
Q2
2013
Feb 29, 2012
$6.0K
May 3, 2013
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($10.09M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($9.87M)
Aug 7, 2025
Q3
2025
Jun 30, 2025
($9.87M)
Nov 13, 2025
Q2
2025
Mar 31, 2025
($17.56M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($17.56M)
May 12, 2025
Q3
2025
Mar 31, 2025
($17.56M)
Nov 13, 2025
Q3
2025
Sep 30, 2024
($21.73M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($17.77M)
Aug 7, 2025
Q3
2025
Jun 30, 2024
($17.77M)
Nov 13, 2025
Q2
2025
Mar 31, 2024
($21.83M)
Aug 7, 2025
Q3
2025
Mar 31, 2024
($21.83M)
Nov 13, 2025
Q1
2025
Mar 31, 2024
($21.83M)
May 12, 2025
Q3
2024
Sep 30, 2023
($22.00M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($25.30M)
Aug 7, 2024
Q3
2024
Jun 30, 2023
($25.30M)
Nov 7, 2024
Q2
2024
Mar 31, 2023
($26.32M)
Aug 7, 2024
Q3
2024
Mar 31, 2023
($26.32M)
Nov 7, 2024
Q1
2024
Mar 31, 2023
($26.32M)
May 8, 2024
Q1
2023
Dec 31, 2022
($39.75M)
May 11, 2023
Q3
2023
Sep 30, 2022
($39.42M)
Nov 8, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($10.33M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($10.22M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($18.22M)
May 12, 2025
Q3
2025
Sep 30, 2024
($23.01M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($18.82M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($22.99M)
May 12, 2025
Q3
2024
Sep 30, 2023
($22.69M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($26.03M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($28.15M)
May 8, 2024
Q1
2023
Dec 31, 2022
($38.30M)
May 11, 2023
Q3
2023
Sep 30, 2022
($38.74M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($45.51M)
Aug 8, 2023
Q1
2022
Mar 31, 2022
($38.30M)
May 5, 2022
Q3
2022
Sep 30, 2021
($42.65M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($26.46M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($22.41M)
May 5, 2022
Q3
2021
Sep 30, 2020
($17.18M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($12.76M)
Aug 10, 2021
Q1
2021
Mar 31, 2020
($9.97M)
May 12, 2021
Q1
2020
Sep 30, 2019
($3.71M)
Nov 13, 2019